SCHEMBL8282111

SCHEMBL8282111

CCOc1ccc(-c2nnc(C)n2-c2cccc(Cl)c2)cc1C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OXTR P30559 6/20 0.61
AVPR1A P37288 7/20 0.47
AVPR2 P30518 2/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GAA P10253 1/20 0.43
TSHR P16473 2/20 0.43
ALDH1A1 P00352 1/20 0.43
CACNA2D1 P54289 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
HPGD P15428 2/20 0.41
LMNA P02545 1/20 0.41
RAB9A P51151 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
KDM4E B2RXH2 1/20 0.40
CYP1A2 P05177 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C19 P33261 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8279809 0.87 OXTR (0.68) OXTRAVPR1AAVPR2CACNA2D1SMN1; SMN2
SCHEMBL8282113 0.82 OXTR (0.71) OXTRAVPR1AAVPR2CACNA2D1SMN1; SMN2
SCHEMBL8281669 0.79 OXTR (0.77) OXTRAVPR1AAVPR2SMN1; SMN2HPGD
SCHEMBL8282112 0.76 OXTR (1.00) OXTRAVPR1AAVPR2
SCHEMBL8281723 0.74 OXTR (0.58) OXTRAVPR1AAVPR2ALDH1A1LMNA
SCHEMBL8280928 0.74 OXTR (0.58) OXTRAVPR1AAVPR2MEN1KMT2A
SCHEMBL6511017 0.70 OXTR (0.80) OXTRAVPR1AAVPR2TUBB4ATUBB
SCHEMBL254428 0.69 HPGD (0.53) MEN1KMT2AGAATSHRALDH1A1
SCHEMBL5832320 0.66 AVPR1A (0.72) OXTRAVPR1AAVPR2
SCHEMBL8282122 0.65 AVPR2 (0.49) OXTRAVPR1AAVPR2GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005082866-A2 SUBSTITUTED 1, 2, 4- TRIAZOLE DERIVATIVES AS OXYTOCIN ANTAGONISTS PFIZER LIMITED (GB) 2005-09-09 WO disclosed